These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12404758)

  • 1. [Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
    Fujii W
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):429-38. PubMed ID: 12404758
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of elastase on the glomerular capillary basement membrane thickening of the experimental congenital diabetic mice (N.S.Y. mice).
    Shibata M; Kawanishi A; Kishi T; Kobayashi K; Kuno T; Sasaki M; Yasuda B
    Nagoya J Med Sci; 1981 Mar; 43(3-4):111-5. PubMed ID: 6912384
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic glomerulopathy in man and experimental animal models.
    Steffes MW; Mauer SM
    Int Rev Exp Pathol; 1984; 26():147-75. PubMed ID: 6400512
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
    Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
    Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of early islet transplantation on prevention of nephropathy in the spontaneously diabetic BB rat.
    Woehrle M; Spitzer D; Linn T; Federlin K; Bretzel RG
    Transplant Proc; 1990 Apr; 22(2):819-20. PubMed ID: 2109409
    [No Abstract]   [Full Text] [Related]  

  • 10. The point of no return in rat diabetic nephropathy: effects of pancreatic transplantation.
    Otsu I; Nozawa M; Tsuchida H; Hirose K
    Transplant Proc; 1992 Jun; 24(3):857-8. PubMed ID: 1604643
    [No Abstract]   [Full Text] [Related]  

  • 11. Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis.
    Yang CW; Vlassara H; Striker GE; Striker LJ
    Kidney Int Suppl; 1995 Jun; 49():S55-8. PubMed ID: 7674596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anionic charge sites in the kidney: comparison of two diabetic rat models.
    Ward-Cook KM; Mahan JD; Frenchko CE; Albright A; Chiasera JM; McAllister C
    Ann Clin Lab Sci; 1999; 29(4):286-98. PubMed ID: 10528828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of glomerular SREBP-1c in diabetic nephropathy.
    Ishigaki N; Yamamoto T; Shimizu Y; Kobayashi K; Yatoh S; Sone H; Takahashi A; Suzuki H; Yamagata K; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2007 Dec; 364(3):502-8. PubMed ID: 17961514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of diabetic nephropathy.
    Mauer SM; Steffes MW; Brown DM
    Adv Nephrol Necker Hosp; 1979; 8():23-42. PubMed ID: 115242
    [No Abstract]   [Full Text] [Related]  

  • 16. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of impaired renal function in rats with streptozotocin-induced diabetes by transplantation of isolated pancreatic islets: failure in preventing the progress of glomerulosclerosis.
    Yamamoto T; Kawamura J; Yoshida O; Tobe T
    Nihon Geka Hokan; 1984 Nov; 53(6):721-35. PubMed ID: 6242013
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
    Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
    Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.